Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Progestagen associated endometrial protein pseudogene 1 (PAEPP1) is a human pseudogene, meaning it resembles a protein-coding gene but does not produce a functional protein. It is located near the active progestagen-associated endometrial protein (PAEP) gene on human chromosome 9, which encodes glycodelin—a member of the lipocalin family involved in reproductive function. PAEPP1 represents the evolutionary remnant of the beta-lactoglobulin gene found in other species; it is not expressed in humans and, as a pseudogene, has no established biological function or role in human disease[2]. It is not recognized as a therapeutic target, and there is no evidence of endogenous expression, disease association, or drug interaction for this locus. Presence of this pseudogene reflects evolutionary loss of milk beta-lactoglobulin function in humans and certain other mammals[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Progestagen associated endometrial protein pseudogene 1 (PAEPP1).